Data management in oncology clinical trials features multiple complexities, and choosing the right EDC system is essential.
Discover why IQVIA Holdings leads in life sciences data & tech with AI-driven services, strong growth, and up to 30% stock ...
RenovoRx will present its findings from a pharmacokinetic and pharmacodynamic sub-study of the Company’s ongoing Phase III TIGeR-PaC clinical trial, led by Dr. Paula Novelli of the University of ...
Strong relational governance between technology vendors and sponsor–CRO teams is becoming a critical foundation for eCOA ...
The push for sustainable dentistry is here, but it's disconnected from the clinical and financial realities of our practices.
The Vendor-Neutral MSP and Real-World Data: Optimizing Workforce Deployment for Post-Market Surveill
In a complex regulatory environment, post-market surveillance is a continuous process that demands precision, adaptability and scale. As life sciences organizations increasingly rely on real-world ...
Digit health technologies (DHT) are a key aspect of U.S. Health & Human Services (HHS) Secretary Robert F. Kennedy Jr.’s Make America Healthy ...
As we look to 2026, there's a bright future for well-governed healthcare information to advance artificial intelligence ...
Roche stock could be interesting for patient investors. Learn more about its outlook, pipeline prospects, and upcoming ...
Trinity Health Chief Health Informatics Officer Murielle Beene shares how health informaticists are approaching artificial ...
We have worked many overnight shifts in the ED caring for a hallway full of admitted patients because there were no inpatient ...
Several of Wall Street's savviest billionaire money managers purchased this stock during the September-ended quarter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback